Picture of Humanigen logo

HGENQ — Humanigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Humanigen Inc reports results for the quarter ended in December - Earnings Summary

* Humanigen Inc  HGEN.OQ  reported quarterly adjusted
earnings of
5 cents​​ per share for the quarter ended in December. The mean
expectation of three analysts for the quarter was for a loss
of 6 cents per share.
    * Revenue fell 78.7% to $221.00 thousand from a year ago;
analysts
expected $100.00 thousand. 
    * Humanigen Inc's reported EPS for the quarter was 5 cents​.
    * The mean earnings estimate of analysts had fallen by
about 63.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Humanigen Inc shares had fallen by 2.4% this quarter and
gained 16.7% so far this year.
    * The company reported quarterly net income of $4.39
million.
    * Wall Street's median 12-month price target for Humanigen
Inc is
$0.33 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
April 4 at 06:35 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.06          0.05           Beat
 Sep. 30 2022      -0.18          -0.23          Missed
 Jun. 30 2022      -0.30          -0.43          Missed
 Mar. 31 2022      -0.46          -0.32          Beat

Recent news on Humanigen

See all news